• Info
  • Insider Ownership

Insider Trading & Ownership of John C. Thomas

Location
Raleigh, NC
Summary
The estimated net worth of John C. Thomas is at least $1,086,143 dollars as of 01 Jul 2025. John C. Thomas is the Former Director of ImmunityBio, Inc. and owns shares of ImmunityBio, Inc. (IBRX) stock worth about $1.09M.
Signature
/s/ Greg Duncan, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow John C. Thomas and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • John C. Thomas has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,086,143.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ImmunityBio, Inc. ($1,086,143).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of John C. Thomas

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IBRX ImmunityBio, Inc. Former Director $1,086,143 31 Dec 2021
DWTX Dogwood Therapeutics, Inc. Director 27 Jun 2025

Insider Transactions Reported by John C. Thomas:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored